18 May 2013
Keywords: genome, therapeutics, changes, name, oscient, firm, says
Article | 19 April 2004
US firm Genome Therapeutics says that, following the merger with Genesoft Pharmaceuticals and to better reflect its focus on drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.